Physician profile
Molly Lee
NPI 1083755037
$1,012.70
in general payments reported to CMS, 2019-2025
17 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $53.52 · 2021: $30.44 · 2022: $304 · 2023: $152 · 2024: $96.28 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $221.34 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Clareon Panoptix Pro, Total30 |
| Biotissue Holdings INC. | $160.69 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $94.45 | 2022-2025 | Infuse, Vyzulta, Xiidra |
| Dompe US, INC. | $93.57 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $57.24 | 2023-2024 | Cequa |
| Allergan, INC. | $56.76 | 2019-2022 | |
| Abbvie INC. | $56.45 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.42 | 2019-2021 | |
| Shire North American Group INC | $41.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.75 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $27.88 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $26.83 | 2022 | |
| Kala Pharmaceuticals, INC. | $26.54 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $17.55 | 2024 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $17.36 | 2025 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $16.10 | 2022 | |
| Aerie Pharmaceuticals, INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.